Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV

Journal of Virology

Volumn 78, Issue 11, 2004, Pages 6043-6047

  Takimoto, Toru ^a   Hurwitz, Julia L ^a   Coleclough, Chris ^a   Prouser, Cecilia ^a   Krishnamurthy, Sateesh ^a   Zhan, Xiaoyan ^a   Boyd, Kelli ^a   Scroggs, Ruth A ^a   Brown, Brita ^a   Nagai, Yoshiyuki ^b   Portner, Allen ^a   Slobod, Karen S ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b TOYAMA INSTITUTE OF HEALTH   (Japan)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; THROMBOSPONDIN; VIRUS VECTOR;

ANTIBODY PRODUCTION; ARTICLE; CERCOPITHECIDAE; CHILDHOOD DISEASE; CLINICAL TRIAL; GENE EXPRESSION; GENE TARGETING; GENETICS; HUMAN; IMMUNE RESPONSE; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; SENDAI VIRUS; VIRUS RECOMBINANT;

ANIMALS; IMMUNIZATION; RESPIRATORY SYNCYTIAL VIRUS VACCINES; SENDAI VIRUS; SIGMODONTINAE; VACCINES, SYNTHETIC; VIRAL PROTEINS;

EID: 2442695260     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.11.6043-6047.2004     Document Type: Article

References (24)

1. Anderson, L. J., R. A. Parker, and R. L. Strikas. 1990. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. J. Infect. Dis. 161:640-646.
2. Bousse, T., T. Matrosovich, A. Portner, A. Kato, Y. Nagai, and T. Takimoto. 2002. The long noncoding region of the human parainfluenza virus type 1 gene contributes to the read-through transcription at the M-F gene junction. J. Virol. 76:8244-8251.
3. Connors, M., A. B. Kulkarni, C.-Y. Firestone, K. L. Holmes, H. C. Morse, A. V. Sotnikov, and B. R. Murphy. 1992. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 66:7444-7451.
4. Crowe, J. E., Jr., P. L. Collins, W. T. London, R. M. Chanock, and B. R. Murphy. 1993. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Vaccine 11:1395-1404.
5. Fulginiti, V. A., J. J. Eller, O. F. Sieber, J. W. Joyner, M. Minamitani, and G. Meiklejohn. 1969. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alumprecipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:435-448.
6. Heilman, C. A. 1990. From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses. J. Infect. Dis. 161:402-406.
7. Hou, S., L. Hyland, K. W. Ryan, A. Portner, and P. C. Doherty. 1994. Virus-specific CD8+ T-cell memory determined by clonal burst. Nature 369:652-654.
8. Hurwitz, J. L., K. F. Soike, M. Y. Sangster, A. Portner, R. E. Sealy, D. H. Dawson, and C. Coleclough. 1997. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine 15:533-540.
9. Ishida, N., and M. Homma. 1978. Sendai virus. Adv. Virus Res. 23:349-383.
10. Kast, W. M., L. Roux, J. Curren, H. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. J. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283-2287.
11. Kato, A., Y. Sakai, T. Shioda, T. Kondo, M. Nakanishi, and Y. Nagai. 1996. Initiation of Sendai virus multiplication from transfected cDNA RNA with negative or positive sense. Genes Cells 1:569-579.
12. Kim, H. W., J. O. Arrobio, G. Pyles, C. D. Brandt, E. Camargo, R. M. Chanock, and R. H. Parrott. 1971. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 48:745-755.
13. Lyn, D., D. S. Gill, R. A. Scroggs, and A. Portner. 1991. The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinants. J. Gen. Virol. 72:983-987.
14. Murphy, B. R., G. A. Prince, E. E. Walsh, H. W. Kim, R. H. Parrott, V. G. Hemming, W. J. Rodriguez, and R. M. Chanock. 1986. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J. Clin. Microbiol. 24:197-202.
15. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
16. Prince, G. A., J. P. Prieels, M. Slaoui, and D. D. Porter. 1999. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). Lab. Investig. 79:1385-1392.
17. Russell, M. W., M. H. Martin, H.-Y. Wu, S. K. Hollingshead, A. Moldoveanu, and J. Mestecky. 2000. Strategies of immunization against mucosal infections. Vaccine 19:S122-S127.
18. Simoes, E. A. F. 1999. Respiratory syncytial virus infection. Lancet 354:847-852.
19. Slobod, K. S., J. L. Shenep, J. Lujan-Zilbermann, K. Allison, B. Brown, R. A. Scroggs, A. Portner, C. Coleclough, J. L. Hurwitz. Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy adults. Vaccine, in press.
20. Smith, F. S., A. Portner, R. J. Leggiadro, E. V. Turner, and J. L. Hurwitz. 1994. Age-related development of human memory T-helper and B-cell responses towards parainfluenza virus-type 1. Virology 205:453-461.
21. Takahashi, T., K. W. Ryan, and A. Portner. 1993. A plasmid that improves the efficiency of foreign gene expression by intracellular T7 RNA polymerase. Genet. Anal. Technol. Appl. 9:91-95.
22. Takimoto, T., T. Bousse, and A. Portner. 2000. Molecular cloning and expression of human parainfluenza virus type 1 L gene. Virus Res. 70:45-53.
23. Takimoto, T., T. Bousse, E. C. Coronel, R. A. Scroggs, and A. Portner. 1998. Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J. Virol. 72:9747-9754.
24. Taylor, G., E. J. Stott, M. Bew, B. F. Fernie, P. J. Cote, A. P. Collins, M. Hughes, and J. Jebbett. 1984. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137-142.